Correlation Between Spectrumone Publ and Kancera AB

Can any of the company-specific risk be diversified away by investing in both Spectrumone Publ and Kancera AB at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spectrumone Publ and Kancera AB into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Spectrumone publ AB and Kancera AB, you can compare the effects of market volatilities on Spectrumone Publ and Kancera AB and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spectrumone Publ with a short position of Kancera AB. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spectrumone Publ and Kancera AB.

Diversification Opportunities for Spectrumone Publ and Kancera AB

-0.16

Correlation Coefficient

Spectrumone Publ  Kancera AB

Good diversification

The 3 months correlation between Spectrumone and Kancera is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding Spectrumone publ AB and Kancera AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kancera AB and Spectrumone Publ is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spectrumone publ AB are associated (or correlated) with Kancera AB. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kancera AB has no effect on the direction of Spectrumone Publ i.e., Spectrumone Publ and Kancera AB go up and down completely randomly.

Pair Corralation between Spectrumone Publ and Kancera AB

Assuming the 90 days trading horizon Spectrumone publ AB is expected to generate 0.62 times more return on investment than Kancera AB. However, Spectrumone publ AB is 1.61 times less risky than Kancera AB. It trades about -0.06 of its potential returns per unit of risk. Kancera AB is currently generating about -0.09 per unit of risk. If you would invest  41.00  in Spectrumone publ AB on November 19, 2024 and sell it today you would lose (14.00) from holding Spectrumone publ AB or give up 34.15% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Spectrumone publ AB  vs.  Kancera AB

Spectrumone publ

Risk-Adjusted Performance

Very Weak

Over the last 90 days Spectrumone publ AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's technical and fundamental indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Kancera AB

Risk-Adjusted Performance

Very Weak

Over the last 90 days Kancera AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Kancera AB is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Spectrumone Publ and Kancera AB

The main advantage of trading using opposite Spectrumone Publ and Kancera AB positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spectrumone Publ position performs unexpectedly, Kancera AB can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kancera AB will offset losses from the drop in Kancera AB's long position.

The idea behind Spectrumone publ AB and Kancera AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.